Tag Archives: Conversion to Dementia From Prodromal Disease

Summary of Recent Progress in Alzheimer’s Disease Prevention Trials (CTAD / JPAD)

Posted on October 1, 2018 by Dementia and Elderly Care News

Summary The following article summarises a round-up of present understanding and developments reflected in current and planned prevention trials, as discussed at a EU / US / Clinical Trials in Alzheimer’s Disease (CTAD) Task Force meeting, as of December 2016-7. … Continue reading →

Investigations Into the Early Signs, Symptoms and Family Experiences of Alzheimer’s Disease (BMJ Open / International Psychogeriatrics)

Posted on May 23, 2018 by Dementia and Elderly Care News

Summary A literature review analyses the sequence / timing of the early signs and symptoms of Alzheimer’s Disease. The authors distinguish between the early signs of late-onset Alzheimer’s Disease (LOAD) and those of early-onset Alzheimer’s Disease (EOAD). Full Text Link … Continue reading →

Posted in Community Care, Depression, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Mental Health, Models of Dementia Care, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged Aberrant Motor Behaviour, Acalculia, Agitation, Alexia, Anomia, Anosognosia, Anxiety, Apathy, Australia, BMJ Open, BMJ Publishing Group Ltd, Box Hill Hospital (Victoria), Cognitive Impairment, Conversion to Dementia From Prodromal Disease, Disinhibition, Early Detection of Preclinical Disease, Early Signs and Symptoms of Alzheimer's Disease, Early-Onset Alzheimer’s Disease (EOAD), Early-Onset Dementia, Eastern Cognitive Disorders Clinic: Box Hill Hospital, Experiences, Experiences of the Transition to Dementia, Family and Caregiver Experiences, Family Members' Experiences of Pre-Diagnostic Phase of Dementia, Hallucination, Initial Onset and Diagnosis, Institute for Health Research: University of Bedfordshire, International Psychogeriatrics, Irritability, Late Onset Dementia, Late-Onset Alzheimer's Disease, Late-Onset Alzheimer's Disease (LOAD), Melbourne School of Psychological Sciences: University of Melbourne, Neuroscience Department: Box Hill Hospital, Olfactory Disturbances, Patient and Carer Experiences, Patient Experiences, Pre-Diagnostic Phase of Dementia, Preclinical Alzheimer's Disease, Preclinical Indicators in Alzheimer's Disease, Preclinical Phase of Dementia, Prodromal Alzheimer's Disease, School of Life Sciences: University of Hull, Signs and Symptoms of Alzheimer's Disease, University of Bedfordshire, University of Hull, University of Melbourne, Weight Loss, Young Onset Dementia (YOD), Young-Onset Dementia | Leave a comment

Blood Test for Pre-Symptomatic Alzheimer’s Disease Likely to Arrive Soon? (BBC News / Nature)

Posted on February 1, 2018 by Dementia and Elderly Care News

Summary A blood test developed by researchers in Australia and Japan appears to be able to predict the risk of developing Alzheimer’s Disease, with 90% accuracy. Detection of amyloid beta in the blood may be taken as a biomarker for … Continue reading →

Posted in BBC News, Diagnosis, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Quick Insights, Universal Interest | Tagged Alzheimer’s Disease, Amyloid Beta, Amyloid-β (Aβ), Austin Health: Australia, Australia, ß-amyloid, BBC Health News, Beta-Amyloid, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Blood Proteins as Biomarkers of Disease Research, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Center for Development of Advanced Medicine for Dementia:: National Center for Geriatrics and Gerontology (Japan), Conversion to Dementia From Prodromal Disease, CSIRO (Brisbane), Edith Cowan University: Western Australia, Florey Institute: University of Melbourne, Health and Biosecurity: CSIRO (Brisbane), Japan, Koichi Tanaka Mass Spectrometry Research Laboratory: Shimadzu Corporation, Koichi Tanaka Mass Spectrometry Research Laboratory: Shimadzu Corporation (Kyoto), Laboratory of Neuropathology and Neuroscience: University of Tokyo, National Center for Geriatrics and Gerontology (Japan), Nature, Non-Invasive Biomarkers, Plasma Amyloid-β Biomarkers for Alzheimer’s Disease, Plasma Biomarkers, Preclinical Biomarkers in Alzheimer's Disease, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Shimadzu Corporation, Shimadzu Corporation (Kyoto), Tokyo Metropolitan Institute of Gerontology, University of Melbourne, University of Tokyo | Leave a comment

Nutritional Intervention to Slow Dementia Progression?: Evidence Still Unclear on Nutricia’s Souvenaid Drink (BBC News / Lancet Neurology / NHS Choices)

Posted on November 3, 2017 by Dementia and Elderly Care News

Summary A LipiDiDiet trial investigated the effects of Fortasyn Connect on cognitive decline (and related measures) in the early stages of Alzheimer’s Disease. This small trial indicates that Nutricia’s nutrient drink Souvenaid has no significant effect on the rate of … Continue reading →

Posted in BBC News, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Non-Pharmacological Treatments, Nutrition, Pharmacological Treatments, Quick Insights, Universal Interest | Tagged Alzheimer Center Limburg: University of Maastricht, Alzheimer Center: VU University Medical Center, Alzheimer's and Dementia: The Journal of the Alzheimer's Association, Alzheimer's and Dementia: Translational Research and Clinical Interventions (TRCI), Alzheimer’s and Dementia (Journal), Amsterdam Neuroscience: VU University Medical Center, BBC Health News, Behind the Headlines, Care Sciences and Society: Karolinska Institute, Clinical Neurochemistry Laboratory: Sahlgrenska University Hospital, Clinical Trials Unit: Karolinska University Hospital, Cognitive Impairment, Conversion to Dementia From Prodromal Disease, Department of Clinical Geriatrics: Karolinska Institute, Department of Experimental Neurology: Saarland University, Department of Geriatric Medicine: Karolinska University Hospital, Department of Neurobiology: Karolinska Institute, Department of Neurology: Kuopio University Hospital, Department of Neurology: University of Eastern Finland, Department of Neurology: VU University Medical Center, Department of Psychiatry and Neurochemistry: Sahlgrenska Academy at University of Gothenburg, Department of Psychiatry and Neuropsychology: University of Maastricht, European Commission 7th Framework Programme, European Community’s Seventh Framework Programme, Fatty Acids, Finland, Fortasyn Connect, German Institute for Dementia Prevention (DIDP), Germany, Improving Nutritional Care, Institute of Clinical Medicine: University of Eastern Finland, Institute of Neuroscience and Physiology: Sahlgrenska Academy at University of Gothenburg, Karolinska Institutet, Karolinska Institutet (Stockholm), Karolinska University Hospital, Kuopio University Hospital, Lancet Neurology, LipiDiDiet Trial, Medical Faculty: Saarland University, Netherlands, Neuneuropsychological Test Battery (NTB), NeuroCenter Kuopio University Hospital, NL-ENIGMA Trial, Nutricia Advanced Medical Nutrition, Nutricia’s Souvenaid Drink, Nutrients, Nutrition and Dementia, Nutrition Support, Nutritional Approaches to Slowing or Arresting Cognitive Impairment / Dementia, Nutritional Interventions, Nutritional Supplementation, Oral Nutritional Supplements, Pentara Corporation (Salt Lake City), Preclinical Alzheimer's Disease, Preclinical Phase of Dementia, Prodromal Alzheimer's Disease, Saarland University (Homburg), Sahlgrenska Academy: University of Gothenburg, Sahlgrenska University Hospital, Souvenaid Drink (Nutricia), Sweden, University of Eastern Finland, University of Gothenburg, University of Maastricht, USA, Vitamins, VU University Medical Center | Leave a comment

Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)

Posted on June 28, 2017 by Dementia and Elderly Care News

Summary The Deep and Frequent Phenotyping Study aims to discover new ways of diagnosing dementia, ideally decades before the symptoms become apparent in order to give future drug treatments the best chance of working. The Deep and Frequent Phenotyping Study … Continue reading →

Posted in Alzheimer's Society, BBC News, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Mental Health, Models of Dementia Care, National, NIHR, Quick Insights, UK, Universal Interest | Tagged Ageing Population, Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Amnestic Mild Cognitive Impairment (a-MCI), Amnestic Mild Cognitive Impairment (aMCI), Applications of Big Data, BBC Radio, BBC Radio 4, BBC's World At One Programme, Big Data Analytics, Big Data Funding and Research, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Neuropsychological Test Automated Battery (CANTAB), Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Deep and Frequent Phenotyping Study (DFP), Deep and Frequent Phenotyping; Combinatorial Biomarkers of Dementia, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, DFP Study Team, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Gait and Cognition, Gait Changes, Gateway to Research (GtR), Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, Join Dementia Research, Join Dementia Research: Clinical Trials Matchmaker Service, Join Dementia Research: Recruitment Onto Dementia Studies, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurobiology of Aging (Journal), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Open Data and Big Data, Ophthalmological Assessments, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, PharmaCog Consortium, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Clare Mackay: Imaging Neuroscience at the University of Oxford, Professor Lynn Rochester: Clinical Ageing Research Unit at Newcastle University, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Publicly-Funded UK Big Data Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Screening Tools for Amnestic Mild Cognitive Impairment (a-MCI), Surrogate Biomarkers of Neurodegeneration, Translational Research, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology) | Leave a comment

Deep and Frequent Phenotyping Study: Dementia Early Detection and Biomarkers Research Programme (MRC / NIHR)

Posted on August 22, 2016 by Dementia and Elderly Care News

Summary The Deep and Frequent Phenotyping Study will explore improvements in biomarker research and the development of tests to detect Alzheimer’s Disease early on. This research programme will be funded by the National Institute of Health Research (NIHR) and the … Continue reading →

Posted in Alzheimer's Society, Charitable Bodies, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, National, NIHR, Quick Insights, UK, Universal Interest | Tagged Alterations in Movement and Walking (“Gait”) Assessments, Alzheimer's Disease: Early Detection by Brain Scan, Alzheimer’s Disease Biomarkers, Aridhia, AstraZeneca / MedImmune, Berry Consultants, Biomarker Assessments in Alzheimer’s Disease, Biomarker Assessments in Alzheimer’s Disease Clinical Trials, Biomarker Assessments in Clinical Trials, Biomarker Development, Biomarkers, Biomarkers Predicting Cognitive Decline and Alzheimer's Disease, Biomarkers Research Programmes, Blood and Urine Biomarkers, Blood-Based Biomarkers, Blood-Based Biomarkers of Pre-Symptomatic Alzheimer’s Disease, Brain Scans, Cambridge Cognition, Cerebrospinal Fluid (CSF) Biomarkers, Clinical Assessments, Cognitive Assessments / Screening Tools, Conversion to Dementia From Prodromal Disease, CSF Biomarkers, Deep and Frequent Phenotyping Study, Dementia Research, Dementia Research Funding, Dementias Platform UK, Dementias Platform UK (DPUK), Dementias Platform UK: MRC, Disease Modifying Treatment by 2025 (Aim), Disease-Modifying Therapies, Disease-Modifying Therapies for Dementia, DPUK: Dementias Platform UK, Dr Rob Buckle: Director of Science Programmes at MRC, Drug Trials Failure Rate, Early Detection of Alzheimer’s Disease, Early Detection of Preclinical Disease, EEG: Electroencephalography, Effectiveness of Early Detection and Treatment, Electroencephalogram (EEG) Brain Scans, Electroencephalography (EEG), Exprodo, Gait and Cognition, Gait Changes, Global Dementia Research, Global Leadership, Hypothetical Prodromes of Dementia, Imanova, Imperial College London, IXICO, Kings College London, Magnetic Resonance Imaging (MRI) Scan, Magnetoencephalography (MEG), Medical Research Council (MRC), Medical Research Council (UK), National Institute of Health Research (NIHR), Neurodegeneration, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neurodegenerative Research, Newcastle University, Non-Invasive Biomarkers, Ocular Manifestations in Neurodegenerative Diseases, Ophthalmological Assessments, Optos, Participation in Research, Participation in Research Studies, Partnership and Collaboration, Patient and Public Participation, Positron Emission Tomography (PET), Pre-Clinical Genotype-Phenotype Predictors of Alzheimer's Disease, Prodromal Alzheimer's Disease, Professor Chris Whitty: Chief Scientific Adviser at Department of Health, Professor Simon Lovestone: Lead Researcher and Professor of Translational Neuroscience at University of Oxford, Protein-Based Biomarkers in Blood May Deliver Accurate Diagnoses, Proteomic Analysis, Proteomics, Public Participation in Research, Research and Development, Research and Innovation, Research Commitment, Research Culture, Research Funding, Retina as Early Biomarker of Neurodegeneration, Retinal Biomarkers, Retinal Changes as Surrogate Biomarker for Alzheimer's Disease, Retinal Ganglion Cells (RGCs), Retinal Manifestations of Alzheimer's Disease, Sage Bionetworks, Surrogate Biomarkers of Neurodegeneration, Translational Research, TrialSpark, University College London, University of Cambridge, University of Edinburgh, University of Manchester, University of Oxford, Volunteers, Walking Pattern (Gait), Wearable Devices, Wearables (Technology), West London Mental Health Trust / Imperial College London | 1 Comment

Exploring the Relationship Between Worsening Depression and Increased Dementia Risk (BBC News / Lancet Psychiatry / JGCR)

Posted on May 1, 2016 by Dementia and Elderly Care News

Summary Researchers in the Netherlands, following 3325 adults aged over 55 years for 11 years, have discovered an association between symptoms of depression which increase steadily over time in older adults and a greater likelihood of developing early signs of … Continue reading →

Posted in BBC News, Depression, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Mental Health, Quick Insights, Statistics, Universal Interest | Tagged Alzheimer's Disease, Association Between Worsening Depression and Increased Dementia Risk, Australia, BBC Health News, Center for Epidemiology Depression Scale (CES-D), Conversion to Dementia From Prodromal Disease, Dementia Risk Factors, Dementia Risk Prevention, Dementia Risk Reduction and Prevention, Department of Developmental Disability and Centre for Healthy Brain Ageing: University of New South Wales, Department of Epidemiology: Erasmus Medical Center, Department of Neurology: Erasmus Medical Center, Department of Psychiatry: Erasmus Medical Center, Department of Psychiatry: King George’s Medical University (India), Department of Radiology: Erasmus Medical Center, Depression and Dementia, Depression in Adults, Depression in Dementia: Risk Factors, Depression in Older People, Depressive Symptoms, Depressive Symptoms (Five Trajectories), Disease Predictors, Early Dementia, Epidemiology, Epidemiology and Statistics, Erasmus Medical Center (Rotterdam), Erasmus University Medical Center, Etiopathogenesis Model of Depression in Dementia, Faculty of Medicine: University of New South Wales, Five Trajectories of Depressive Symptoms, Hospital Anxiety and Depression Scale-Depression, Hypothetical Prodromes of Dementia, Increasing Depressive Symptoms, Increasing Depressive Symptoms Associated with a Higher Risk of Dementia, Increasing Depressive Symptoms: Statistical Prodrome of Dementia, India, Journal of Geriatric Care and Research (JGCR), King George’s Medical University (India), Lancet Psychiatry, Latent Class Trajectory Modelling, Netherlands, Netherlands Ministry for Health Welfare and Sports, Netherlands Ministry of Education Culture and Science, Overlapping Risk Factors, Patterns of Depression, Prodromal Alzheimer's Disease, Risk Factors, Risk Factors of Depression and Dementia in Elderly, Risk Prediction and Stratification, Rotterdam (Netherlands), School of Psychiatry: University of New South Wales, Trajectories of Depression, Trajectories of Depressive Symptoms and Risk of Dementia, University of New South Wales, Worsening Depression, Worsening Depression and Elevated Dementia Risk | Leave a comment

Tag Archives: Conversion to Dementia From Prodromal Disease

Blood Test for Pre-Symptomatic Alzheimer’s Disease Likely to Arrive Soon? (BBC News / Nature)

Nutritional Intervention to Slow Dementia Progression?: Evidence Still Unclear on Nutricia’s Souvenaid Drink (BBC News / Lancet Neurology / NHS Choices)

Earlier Diagnosis Research: the Deep and Frequent Phenotyping Study (BBC News / GtR)

Deep and Frequent Phenotyping Study: Dementia Early Detection and Biomarkers Research Programme (MRC / NIHR)

Exploring the Relationship Between Worsening Depression and Increased Dementia Risk (BBC News / Lancet Psychiatry / JGCR)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites